L’allo-immunisation érythrocytaire fœtomaternelle dans le système ABO reste la principale cause des maladies hémolytiques du fœtus et du nouveau-né. Objectif: Énoncer une directive sur le recours au traitement prophylactique anti-D dans le but d’optimiser la prévention d el’allo-immunisation fœto-maternelle. Prévention de l’allo-immunisation fœto-maternelle Rh: en sommes-nous là? Division de la médecine fœto-maternelle, et présidente associée, Éducation).
|Published (Last):||17 December 2013|
|PDF File Size:||12.8 Mb|
|ePub File Size:||12.58 Mb|
|Price:||Free* [*Free Regsitration Required]|
Outline Masquer le plan.
However, despite a great deal of progress, we should not loose sight of the fact that these tests immunksation only an indirect measurement and will only help the obstetrician, in conjunction with other fetal parameters, to assess the severity of the haemolytic disease HD of the fetus and newborn.
Journal page Archives Contents list.
Manual titration is simple but only provides rough, semiquantitatives estimates of anti-RH concentration. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted. The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third imminisation.
Contact Help Who are we? Access to the full text of this article requires a subscription. You can move this window by clicking on the headline. If you want to subscribe to this journal, see our rates You can purchase this item in Pay Per View: Transfert des anticorps maternels vers le foetus.
No Prévention de l’allo-immunisation fœto-maternelle Rh.
If you are a subscriber, please sign in ‘My Account’ at the top right of the screen. The perfect technique for anti-RH quantitation has not been developed. Access to the PDF text. Treatment depends on the total serum bilirubin level, which may immunisatiion very rapidly in the first 48 h of life in cases of hemolytic disease of the newborn.
Journal page Archives Contents list. Outline Masquer le plan. Access to the text HTML.
There was a problem providing the content you requested
Top of the page – Article Outline. As per the Law relating to information storage and personal integrity, you have the jaternelle to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data.
If you want to subscribe to this journal, see our rates You can purchase this item in Pay Foetoo View: We report on three cases showing that ABO allo-immunization can lead to severe hemolytic disease of the newborn with potentially threatening hyperbilirubinemia and complications. The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Suivi de l’allo-immunisation foeto-maternelle – EM|consulte
You can move this window by clicking on the headline. Intensity immunisatikn generally lower than in RhD allo-immunization. Intravenous immunoglobulins are used to reduce exchange transfusion.
Minon bJ. Treatments of severe hemolytic disease of the newborn should be provided and performed by trained personnel in neonatal intensive care units. Early diagnosis and adequate care are necessary to prevent complications in ABO incompatibility. Phototherapy and, in severe cases, exchange transfusion are used to prevent hyperbilirubinemia encephalopathy. Vigilance is even more important for infants discharged before the age of 72 h.
Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care.
No 133-Prévention de l’allo-immunisation fœto-maternelle Rh.
Personal information regarding our website’s visitors, including their identity, is confidential. Access to the text HTML. The best method to assess the severity is the direct determination of foetal blood group hemoglobin after foetal blood sampling but this procedure is not without risk. A direct antiglobulin test is the cornerstone of diagnosis and should be performed at birth on cord blood sampling in all group infants born to O mothers, especially if of African origin.
Since 10 years ago, it is possible to determine the RHD genotype of the fetus using amniocytes and, today, maternal plasma directly. The trend in anti-RH levels is more important than the level itself. Haemolytic disease of the fetus and newborn ; Detection of irregular antibodies ; Antibody titration ; Anti-rh quantitation ; RHD genotyping.